Dr. Yale Wang and RADIANCE-HTN Study in Star Tribune


MHIF Researcher, Dr. Yale Wang was recently interviewed by Joe Carlson of the Star Tribune about renal denervation, an emerging technology for treating resistant high blood pressure.

“As there is no single physiologic cause for hypertension…complementary medications and device therapies must be considered,” Wang said. “At the end of the day, I believe all treatments will be complementary for the better care of our patients.”

Minneapolis Heart Institute Foundation is currently enrolling four different renal denervation studies for high blood pressure. Learn more about the RADIANCE study here: https://highbptrial.com/

Read the full article here: http://www.startribune.com/high-blood-pressure-is-billion-dollar-target-for-device-makers/509449331/